ARCHIVES

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

ACS Recommends MRI For Some Women At High Risk

March 30, 2007

Legislation Would Create Medicare Service For Comprehensive Cancer Care planning.

May 26, 2006

M.D. Anderson Must Evaluate 8 Patients In Controversial Study

May 31, 1996

Institute of Medicine Elects 80 New Members

October 24, 2014

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014

Governors Hear Pitch For State Cancer Control Increased Effort

August 3, 1979